Piotr Radziszewski
Piotr Radziszewski
Department of Urology, Medical University of Warsaw, Poland
Verified email at - Homepage
Cited by
Cited by
EAU guidelines on neurogenic lower urinary tract dysfunction
M Stöhrer, B Blok, D Castro-Diaz, E Chartier-Kastler, G Del Popolo, ...
European urology 56 (1), 81-88, 2009
Efficacy and tolerability of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European–Australian phase 3 trial
V Khullar, G Amarenco, JC Angulo, J Cambronero, K Høye, I Milsom, ...
European urology 63 (2), 283-295, 2013
OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a …
C Chapple, KD Sievert, S MacDiarmid, V Khullar, P Radziszewski, ...
European urology 64 (2), 249-256, 2013
Botulinum toxin a has antinociceptive effects in treating interstitial cystitis
CP Smith, P Radziszewski, A Borkowski, GT Somogyi, TB Boone, ...
Urology 64 (5), 871-875, 2004
Fournier’s gangrene–current concepts
M Wroblewska, B Kuzaka, T Borkowski, P Kuzaka, D Kawecki, ...
Polish Journal of Microbiology 63 (3), 267, 2014
Durable efficacy and safety of long-term onabotulinumtoxinA treatment in patients with overactive bladder syndrome: final results of a 3.5-year study
VW Nitti, D Ginsberg, KD Sievert, D Sussman, S Radomski, P Sand, ...
The Journal of urology 196 (3), 791-800, 2016
OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo …
CJ Fowler, S Auerbach, D Ginsberg, D Hale, P Radziszewski, ...
European Urology 62 (1), 148-157, 2012
Neurogenic lower urinary tract dysfunction: Clinical management recommendations of the Neurologic Incontinence committee of the fifth International Consultation on Incontinence …
MJ Drake, A Apostolidis, A Cocci, A Emmanuel, JB Gajewski, ...
Neurourology and urodynamics 35 (6), 657-665, 2016
Neurologic urinary incontinence
JJ Wyndaele, A Kovindha, H Madersbacher, P Radziszewski, A Ruffion, ...
Neurourology and Urodynamics: Official Journal of the International …, 2010
Fournier’s gangrene: clinical presentation of 13 cases
B Kuzaka, MM Wróblewska, T Borkowski, D Kawecki, P Kuzaka, ...
Medical science monitor: international medical journal of experimental and …, 2018
Safety and tolerability of the β3‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week …
VW Nitti, CR Chapple, C Walters, MB Blauwet, S Herschorn, I Milsom, ...
International journal of clinical practice 68 (8), 972-985, 2014
Guidelines on neurogenic lower urinary tract dysfunction
J Pannek, M Stöhrer, B Blok, D Castro-Diaz, G Del Popolo, G Kramer, ...
European Association of Urology, 1-64, 2011
Neurogenic bowel dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013
N Cotterill, H Madersbacher, JJ Wyndaele, A Apostolidis, MJ Drake, ...
Neurourology and urodynamics 37 (1), 46-53, 2018
Varicocele as a source of male infertility–current treatment techniques
Ł Kupis, PA Dobroński, P Radziszewski
Central European journal of urology 68 (3), 365, 2015
Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years
MC Michel, P Radziszewski, C Falconer, D Marschall‐Kehrel, K Blot
British journal of clinical pharmacology 73 (5), 821-825, 2012
Botulinum toxin type A intravesical injections for intractable bladder overactivity
P Radziszewski, A Borkowski
European Urology Supplements 1 (1), 134, 2002
Neurological urinary and faecal incontinence
M Drake, A Apostolidis, A Emmanuel, J Gajewski, S Harrison, ...
International Consultation on Incontinence, 2012
Mechanisms of action of botulinum neurotoxins, β3‐adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI …
A Kanai, I Zabbarova, M Oefelein, P Radziszewski, Y Ikeda, ...
Neurourology and Urodynamics 31 (3), 300-308, 2012
Distribution and neurochemical characterization of sensory dorsal root ganglia neurons supplying porcine urinary bladder
A Bossowska, R Crayton, P Radziszewski, Z Kmiec, M Majewski
J Physiol Pharmacol 60 (Suppl 4), 77-81, 2009
Treatment of the non-neurogenic storage and voiding disorders with the chemical denervation caused by botulinum toxin type A: a pilot study
P Radziszewski
Neurourol. Urodyn. 20, 410, 2001
The system can't perform the operation now. Try again later.
Articles 1–20